Puncture patch loaded with compound lidocaine cream

Abstract

The utility model discloses a puncture patch loaded with compound lidocaine emulsifiable paste, which relates to the technical field of compound lidocaine emulsifiable paste patches and comprises a compound lidocaine emulsifiable paste patch component, and fixing structures are fixedly mounted on the periphery of the outer wall of the compound lidocaine emulsifiable paste patch component. A double-sided attaching assembly is attached to the upper end of the compound lidocaine emulsifiable paste attaching assembly, a patient can attach compound lidocaine emulsifiable paste to the upper portion of an infusion base for one hour before infusion or maintenance according to the needs of the patient, the purpose of painlessness is achieved when the patient inserts a needle, the emulsifiable paste is wiped cleanly with a cotton swab after one hour, and the patient can conveniently use the compound lidocaine emulsifiable paste. A doctor punctures a patient after conventionally disinfecting the skin of the patient, and the compound lidocaine cream is used, so that the analgesic effect is obvious when the patient punctures, the administration dosage is accurate, the absorption area is fixed, the compound lidocaine cream can be added, reduced and replaced at any time, and the puncture pain of the patient is reduced.

Description

Technical Field

[0001] The utility model relates to the technical field of compound lidocaine cream patches, in particular to a puncture patch loaded with compound lidocaine cream. Background Art

[0002] A fully implantable intravenous infusion port is an intravenous infusion device that can be implanted subcutaneously and left in the body for a long time. It consists of an infusion seat and a radioactive intravenous catheter system and is suitable for patients with long-term chemotherapy and intravenous nutrition for tumors.

[0003] At present, cancer patients complain that repeated punctures of infusion ports cause pain. The reasons for the pain in cancer patients can be roughly divided into two types: First, the negative emotions of cancer patients directly affect the endocrine system and autonomic nervous system of the hypothalamus, causing abnormalities in body fluids, hormones, and enzymes, leading to an increase in endogenous pain-causing substances, a decrease in pain-suppressing substances, and a decrease in pain thresholds. Mental tension and increased attention before puncture will increase the focus on pain. Second, the subjective pain of cancer patients is enhanced. Due to the dense nerve endings on the surface of the skin, when patients with tumor implanted infusion ports are infused or maintained, the non-damaging needle is used to penetrate the epidermis, dermis and subcutaneous tissue to enter the infusion port. The patient will be very sensitive to pain and feel pain; the pain caused by repeated punctures of the infusion port will aggravate the discomfort of cancer patients during treatment;

[0004] In view of the above problems, a puncture patch loaded with compound lidocaine cream is proposed. Summary of the invention

[0005] The utility model aims to provide a puncture patch loaded with compound lidocaine cream, and adopts the device to work, thereby solving the problem that the pain caused by repeated puncture of the infusion port of tumor patients in the above background will aggravate the discomfort of patients during treatment.

[0006] To achieve the above-mentioned purpose, the utility model provides the following technical solutions: a puncture patch loaded with compound lidocaine cream, comprising a compound lidocaine cream patch assembly, wherein a fixing structure is fixedly installed around the outer wall of the compound lidocaine cream patch assembly, and a double-sided bonding assembly is pasted on the upper end of the compound lidocaine cream patch assembly. The fixing structure is used to fix the compound lidocaine cream patch assembly to the upper end of a pre-buried infusion port in the body of a tumor patient, the compound lidocaine cream patch assembly is used to anesthetize the local skin covered by it, and the double-sided bonding assembly is used to protect the unused surface of the compound lidocaine cream patch assembly.

[0007] Furthermore, the compound lidocaine cream patch assembly includes a fitted tablet and a compound lidocaine cream arranged on an upper end of one side of the fitted tablet.

[0008] Furthermore, the fixing structure includes an elastic soft adhesive tape and a vertical rubber block arranged in the middle of one side of the elastic soft adhesive tape, and a long adhesive piece is embedded in one end of the other side of the elastic soft adhesive tape.

[0009] Furthermore, the double-sided laminating assembly includes a laminating layer and an auxiliary mechanism fixedly installed on one side of the upper end of the laminating layer, and corresponding films are embedded around the upper end of the laminating layer.

[0010] Furthermore, the auxiliary mechanism includes a fitting strap and a pulling strap fixedly installed on one side of the upper end of the fitting strap.

[0011] Furthermore, the fitting bandage is configured to drive the fitting layer to be torn off from the upper end of the compound lidocaine cream.

[0012] Compared with the prior art, the beneficial effects of the utility model are as follows: patients can stick the compound lidocaine cream on the infusion seat for one hour before infusion or maintenance according to their own needs, so that patients can achieve painless needle insertion. After one hour, use a cotton swab to wipe off the cream. The doctor punctures the patient after routine skin disinfection. Through the use of the compound lidocaine cream, the patient has a significant analgesic effect during puncture, and the dosage is accurate, the absorption area is fixed, and it can be added or subtracted at any time to reduce the patient's puncture pain. BRIEF DESCRIPTION OF THE DRAWINGS

[0013] Figure 1 It is a schematic diagram of the overall three-dimensional structure of the utility model;

[0014] Figure 2 It is a three-dimensional structural diagram of the fixed structure of the utility model;

[0015] Figure 3 It is a schematic diagram of the three-dimensional structure of the double-sided laminating component of the utility model;

[0016] Figure 4 This is a schematic diagram of the three-dimensional structure of the auxiliary mechanism of the utility model;

[0017] Figure 5 For the utility model Figure 4 Enlarged view of point A.

[0018] In the figure: 1. Compound lidocaine cream patch structure; 11. Laminating tablet; 12. Compound lidocaine cream; 2. Fixing structure; 21. Elastic soft tape; 22. Vertical rubber block; 23. Glued long piece; 3. Double-sided laminating component; 31. Laminating layer; 32. Auxiliary mechanism; 321. Laminating strap; 322. Pulling belt; 33. Corresponding film. DETAILED DESCRIPTION

[0019] The following will be combined with the drawings in the embodiments of the utility model to clearly and completely describe the technical solutions in the embodiments of the utility model. Obviously, the described embodiments are only part of the embodiments of the utility model, not all of the embodiments. Based on the embodiments in the utility model, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the utility model.

[0020] In order to further understand the content of the utility model, the utility model is described in detail in conjunction with the accompanying drawings.

[0021] Combination Figure 1 The utility model discloses a puncture patch loaded with compound lidocaine cream, comprising a compound lidocaine cream patch component 1, a fixing structure 2 is fixedly installed around the outer wall of the compound lidocaine cream patch component 1, a double-sided laminating component 3 is pasted on the upper end of the compound lidocaine cream patch component 1, the fixing structure 2 is used to fix the compound lidocaine cream patch component 1 to the upper end of the pre-buried infusion port of the tumor patient's body, the compound lidocaine cream patch component 1 is used to anesthetize the local skin covered by it, and the double-sided laminating component 3 is used to protect the unused surface of the compound lidocaine cream patch component 1.

[0022] The utility model is further described below in conjunction with embodiments. Example

[0023] See also Figure 1-Figure 5 The compound lidocaine cream patch assembly 1 includes a fitted tablet 11 and a compound lidocaine cream 12 arranged on the upper end of one side of the fitted tablet 11. The compound lidocaine cream 12 is a compound external preparation, the main ingredients of which are prilocaine and lidocaine, both of which are local anesthetics. When this product is used on undamaged skin or mucous membrane surfaces, it can release lidocaine and prilocaine to the cortex and subcutaneous layer, and the two achieve the anesthetic effect of the cortex by accumulating in the cortical pain receptors and nerve endings.

[0024] Specifically, the patient can stick the compound lidocaine cream 12 on the infusion seat for one hour before infusion or maintenance according to his own needs, so that the patient can achieve painless insertion of the needle. After one hour, use a cotton swab to wipe off the cream, and the doctor will puncture the patient after routine skin disinfection. Through the use of the compound lidocaine cream 12, the patient can have a significant analgesic effect during puncture, and the dosage is accurate, the absorption area is fixed, and it can be added or subtracted at any time to reduce the patient's puncture pain. Example

[0025] See also Figure 3-Figure 4The fixing structure 2 includes an elastic soft adhesive tape 21 and an upright rubber block 22 arranged in the middle of one side of the elastic soft adhesive tape 21, and a long adhesive piece 23 is embedded in one end of the other side of the elastic soft adhesive tape 21. The upright rubber block 22 is used to assist in tearing the long adhesive piece 23 from the upper end of the bonding layer 31.

[0026] The double-sided laminating component 3 includes a laminating layer 31 and an auxiliary mechanism 32 fixedly installed on one side of the upper end of the laminating layer 31. The upper end of the laminating layer 31 is embedded with corresponding films 33. The laminating layer 31 is attached to the upper end of the laminating tablet 11, i.e., the compound lidocaine cream 12, to cover the compound lidocaine cream 12. The elastic soft adhesive tape 21 respectively arranged around the outer wall of the laminating tablet 11 is pulled to drive the adhesive long piece 23 and the corresponding film 33 to be glued and connected, thereby completing the reinforcement setting of the laminating layer 31.

[0027] The auxiliary mechanism 32 includes a fitting strap 321 and a pulling strap 322 fixedly installed on one side of the upper end of the fitting strap 321 . The fitting strap 321 is configured to drive the fitting layer 31 to be torn off from the upper end of the compound lidocaine cream 12 .

[0028] Specifically, when the operator uses the compound lidocaine cream 12, he first pulls the upright rubber block 22 in sequence, so that the upright rubber block 22 drives the glued long piece 23 attached to the corresponding film 33 to be lifted up, and then the elastic soft adhesive tape 21 drives the glued long piece 23 to be separated from the upper end of the bonding layer 31 in sequence. The operator pulls the pulling belt 322 to drive the bonding strap 321 to tilt up, and drives the lower end of the bonding layer 31 to be separated from the upper end of the compound lidocaine cream 12 by pulling the tilted bonding strap 321. The operator aligns one side of the bonding tablet 11 provided with the compound lidocaine cream 12 with the upper end of the infusion port, and the glued long piece 23 fixedly arranged around the bonding tablet 11 by the elastic soft adhesive tape 21 is adhered to the skin around the upper end of the infusion port, so as to facilitate the tearing and removal of the bonding tablet 11.

[0029] In summary, when the operator uses the compound lidocaine cream 12, he first pulls the upright rubber block 22 in sequence, so that the upright rubber block 22 drives the glued long piece 23 attached to the corresponding film 33 to be opened, and then the elastic soft adhesive tape 21 drives the glued long piece 23 to be separated from the upper end of the bonding layer 31 in sequence, and the operator pulls the pulling belt 322 to drive the bonding band 321 to tilt up, and by pulling the tilted bonding band 321, the lower end of the bonding layer 31 is separated from the upper end of the compound lidocaine cream 12, and the operator sets the compound lidocaine cream 12 with the compound lidocaine cream 12. Because one side of the cream 12 that fits the tablet 11 is aligned with the upper end of the infusion port, the patient can stick the compound lidocaine cream 12 on the infusion seat for one hour before infusion or maintenance according to his or her own needs, so that the patient can achieve painless needle insertion. After one hour, the cream is wiped clean with a cotton swab, and the doctor punctures the patient after routine skin disinfection. Through the use of the compound lidocaine cream 12, the patient has a significant analgesic effect during puncture, and the dosage is accurate, the absorption area is fixed, and it can be added or subtracted at any time to reduce the patient's puncture pain.

[0030] The contents not described in detail in this specification belong to the prior art known to professional and technical personnel in this field.

[0031] It should be noted that, in this article, relational terms such as first and second, etc. are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Moreover, the terms "include", "comprise" or any other variants thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device.

[0032] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A puncture patch loaded with a compound lidocaine cream, comprising a compound lidocaine cream patch component (1), characterized in that: The outer wall of the compound lidocaine cream patch component (1) is fixedly mounted with a fixing structure (2) around its periphery, and the upper end of the compound lidocaine cream patch component (1) is bonded with a double-sided bonding component (3). The fixing structure (2) is used to fix the compound lidocaine cream patch component (1) to the upper end of a pre-buried infusion port in the body of a tumor patient, the compound lidocaine cream patch component (1) is used to anesthetize the local skin covered by the compound lidocaine cream patch component (1), and the double-sided bonding component (3) is used to protect the unused surface of the compound lidocaine cream patch component (1).

2. The puncture patch loaded with compound lidocaine cream according to claim 1, characterized in that: The compound lidocaine cream patch assembly (1) comprises a patch tablet (11) and a compound lidocaine cream (12) arranged on an upper end of one side of the patch tablet (11).

3. The puncture patch loaded with compound lidocaine cream according to claim 2, characterized in that: The fixing structure (2) comprises an elastic soft adhesive tape (21) and a vertical adhesive block (22) arranged in the middle of one side of the elastic soft adhesive tape (21), and a long adhesive piece (23) is embedded in one end of the other side of the elastic soft adhesive tape (21).

4. The puncture patch loaded with compound lidocaine cream according to claim 3, characterized in that: The double-sided laminating component (3) comprises a laminating layer (31) and an auxiliary mechanism (32) fixedly mounted on one side of the upper end of the laminating layer (31), and corresponding films (33) are embedded around the upper end of the laminating layer (31).

5. The puncture patch loaded with compound lidocaine cream according to claim 4, characterized in that: The auxiliary mechanism (32) comprises a fitting band (321) and a pulling band (322) fixedly mounted on one side of the upper end of the fitting band (321).

6. The puncture patch loaded with compound lidocaine cream according to claim 5, characterized in that: The fitting bandage (321) is configured to drive the fitting layer (31) to be torn off from the upper end of the compound lidocaine cream (12).

Images